Skip to content

Celcuity CELC Debt-to-equity

Debt-to-equity at other companies

Eli Lilly logo
Eli LillyLLY
1.4×-1.1×
Gilead Sciences logo
Gilead SciencesGILD
0.9×-0.4×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
0.0×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-0.1×
Tango Therapeutics logo
Tango TherapeuticsTNGX
0.1×-0.1×
CG Oncology logo
CG OncologyCGON
0.0×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's debt-to-equity?
Celcuity (CELC) reported debt-to-equity of 2.6× in Q1 2026.
How has Celcuity's debt-to-equity changed year-over-year?
Celcuity's debt-to-equity increased by 111.6% year-over-year, from 1.2× to 2.6×.
What is the long-term trend for Celcuity's debt-to-equity?
Over 5 years (2020 to 2025), Celcuity's debt-to-equity has grown at a 120.4% compound annual growth rate (CAGR), from 0× to 1.4×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.